http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2420292-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
filingDate 2001-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f35ea76c267ec8fde57741485a059f1
publicationDate 2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2420292-C
titleOfInvention Contraception process and administration form for the same
abstract Process for hormonal contraception, in which in a plurality of substantially time-unlimited, linked taking periods and optionally having a sequence lasting several years and which in each case comprise at least one taking cycle with a duration-constant taking phase lasting several days within the particular taking period and a taking pause lasting several days, in which taking phase or phases per day administration takes place of a daily unit with at least one contraceptively acting hormone component, such as estrogen and/or gestagen, and in the taking pause or pauses administration takes place either of placebos free from any hormone component or the particular taking pause remains entirely administration-free and the duration of the taking phase or phases of at least the final taking period last at least 22 days, characterized in that the duration of the taking phase or phases in any taking period proceding a following taking period is shorter than in each case following taking period, as well as administration form for hormonal contraception and in particular for the performance thereof.
priorityDate 2000-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175

Total number of triples: 64.